Brian J. Donnelly is the Chief Commercial Officer at Myriad Genetics Inc., a precision medicine company renowned for its genetic testing solutions in oncology, women's health, and hereditary cancer risk assessment. With over 25 years of executive experience in the diagnostics and biotechnology sectors, Brian has a proven track record of driving commercial growth and market expansion. He joined Myriad in 2020 as Senior Vice President of Commercial Operations before ascending to his current role, where he oversees global sales, marketing, customer success, and business development strategies to accelerate the adoption of Myriad's innovative genomic tests. Throughout his career, Brian has held senior leadership positions at leading healthcare companies, including Genomic Health (now Exact Sciences), where he served as Vice President of U.S. Sales and led teams that achieved double-digit revenue growth year-over-year. Earlier roles at Abbott Laboratories and Roche Diagnostics honed his expertise in launching blockbuster diagnostics products and building high-performing commercial organizations. His achievements include spearheading the commercialization of multi-billion-dollar portfolios, expanding market access through payer negotiations, and fostering partnerships that enhanced patient outcomes. At Myriad Genetics, Brian plays a pivotal role in advancing the company's mission to personalize medical care through genetics. Under his leadership, Myriad has strengthened its commercial infrastructure, resulting in significant increases in test volume and market penetration, particularly for its myRisk® Hereditary Cancer Test and Prequel™ Prenatal Screening. Brian's strategic vision continues to position Myriad as a leader in the evolving precision medicine landscape.